REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · Real-Time Price · USD
9.14
+0.45 (5.18%)
At close: Mar 4, 2026, 4:00 PM EST
9.41
+0.27 (2.95%)
After-hours: Mar 4, 2026, 7:59 PM EST
REGENXBIO Market Cap
REGENXBIO has a market cap or net worth of $462.7 million as of March 4, 2026. Its market cap has increased by 27.92% in one year.
Market Cap
462.70M
Enterprise Value
428.79M
1-Year Change
27.92%
Ranking
Category
Stock Price
$9.14
Market Cap Chart
Since September 17, 2015, REGENXBIO's market cap has decreased from $749.30M to $462.70M, a decrease of -38.25%. That is a compound annual growth rate of -4.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 439.90M | -39.66% |
| Dec 31, 2025 | 729.00M | 90.34% |
| Dec 31, 2024 | 383.00M | -51.50% |
| Dec 29, 2023 | 789.70M | -19.57% |
| Dec 30, 2022 | 981.90M | -29.79% |
| Dec 31, 2021 | 1.40B | -17.57% |
| Dec 31, 2020 | 1.70B | 12.32% |
| Dec 31, 2019 | 1.51B | 0.48% |
| Dec 31, 2018 | 1.50B | 45.18% |
| Dec 29, 2017 | 1.04B | 110.87% |
| Dec 30, 2016 | 491.10M | 12.43% |
| Dec 31, 2015 | 436.80M | -41.71% |
| Sep 17, 2015 | 749.30M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kyverna Therapeutics | 486.17M |
| Invivyd | 485.02M |
| Solid Biosciences | 483.04M |
| Vanda Pharmaceuticals | 482.91M |
| 4D Molecular Therapeutics | 475.90M |
| Lineage Cell Therapeutics | 472.54M |
| Tenax Therapeutics | 471.43M |
| Assembly Biosciences | 469.45M |